Clinical Trials Logo

Filter by:
NCT ID: NCT00935181 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Respiratory Muscle Stretching in Chronic Obstructive Pulmonary Disease (COPD)

Start date: January 2006
Phase: Phase 4
Study type: Interventional

Objective: The investigators studied the effects of respiratory muscle stretching in an 8-week pulmonary rehabilitation program. Methods: This was a simple-blind parallel controlled trial, conducted an out-patient clinic. Twenty six patients with COPD (mean age 68 ± 6 y, percent of predicted FEV1 47 ± 16) were randomized to either respiratory muscle stretching group plus exercise training (RMS), and exercise training group (Sham), in an 8-week exercise program that had 3 sessions per week. The investigators measured inspiratory and expiratory muscle strength (by maximal inspiratory and expiratory pressure - PIM and PEM), exercise capacity (by 6-minute walk distance), dyspnea and quality of life.

NCT ID: NCT00934037 Completed - Clinical trials for Coronary Artery Disease

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Core320
Start date: December 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the diagnostic accuracy of multi-detector computed tomography using 320 detectors for identifying the combination of coronary artery stenosis ≥ 50% and a corresponding myocardium perfusion defect in a patient with suspected coronary artery disease compared with conventional coronary angiography and single photon emission computed tomography myocardium perfusion imaging.

NCT ID: NCT00934011 Completed - Septic Shock Clinical Trials

Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections

Start date: September 2009
Phase: N/A
Study type: Interventional

In this study the investigators aim to test if C-reactive protein (CRP)or procalcitonin(PCT) - guided strategy allows to reduce the antibiotic use in patients wiht severe sepsis and septic shock. Therefore, the safety of this intervention will be carefully measured.

NCT ID: NCT00933946 Completed - Hygiene Clinical Trials

Dermacyd Silver Frutal (Lactic Acid) - Compatibility.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Silver Frutal.

NCT ID: NCT00933907 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on Frutal

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDESILSTYFR.

NCT ID: NCT00933842 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on Floral

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd PHDESILSTYFL. Secondary Objective:

NCT ID: NCT00933712 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Compatibility.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Silver Floral

NCT ID: NCT00933699 Completed - Hygiene Clinical Trials

Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.

NCT ID: NCT00933569 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Acceptability.

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To prove the safety of the gynaecological formulation in normal conditions of use.

NCT ID: NCT00933504 Completed - Hygiene Clinical Trials

Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral

Start date: June 2009
Phase: Phase 3
Study type: Interventional

Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDESILSTYFL.